CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
19.60
5.55%
Market Trading Hours* (UTC) Opens on Tuesday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.18
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 18.57
Open 19.03
1-Year Change -35.32%
Day's Range 18.73 - 19.95
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 22, 2024 19.60 0.93 4.98% 18.67 20.04 18.67
Jul 19, 2024 18.57 0.41 2.26% 18.16 18.71 17.96
Jul 18, 2024 18.70 0.02 0.11% 18.68 19.36 18.56
Jul 17, 2024 18.62 0.53 2.93% 18.09 18.84 17.96
Jul 16, 2024 18.51 0.61 3.41% 17.90 18.79 17.78
Jul 15, 2024 17.94 0.15 0.84% 17.79 18.13 17.42
Jul 12, 2024 17.93 0.02 0.11% 17.91 18.78 17.78
Jul 11, 2024 17.78 0.76 4.47% 17.02 17.85 16.97
Jul 10, 2024 16.95 0.54 3.29% 16.41 17.25 16.41
Jul 9, 2024 16.53 0.08 0.49% 16.45 16.73 16.09
Jul 8, 2024 16.89 0.10 0.60% 16.79 17.27 16.78
Jul 5, 2024 17.22 0.08 0.47% 17.14 17.52 16.95
Jul 3, 2024 17.17 -0.09 -0.52% 17.26 17.65 17.10
Jul 2, 2024 17.31 0.40 2.37% 16.91 17.31 16.81
Jul 1, 2024 17.24 0.08 0.47% 17.16 17.88 16.91
Jun 28, 2024 17.27 0.32 1.89% 16.95 17.48 16.74
Jun 27, 2024 17.45 0.27 1.57% 17.18 17.81 17.09
Jun 26, 2024 17.84 -0.19 -1.05% 18.03 18.11 17.65
Jun 25, 2024 18.45 0.45 2.50% 18.00 18.63 17.95
Jun 24, 2024 18.67 0.51 2.81% 18.16 18.85 18.16

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Zai Lab Limited Company profile

Zai Lab Limited, a biopharmaceutical company, engages in discovering or licensing, developing, and commercializing proprietary therapeutics that address medical needs in the fields of oncology, and autoimmune and infectious disease therapies in the People's Republic of China. Its drug candidates include ZL-2306, a poly ADP ribose polymerase 1/2 inhibitor, which is in Phase III clinical trial for the treatment of ovarian, lung, and breast cancers; ZL-2401, an antibiotic that is in Phase III clinical trial to treat ABSSSI, CABP, and UTI; FPA144, a humanized monoclonal antibody, which is in Phase I/III clinical trial to treat gastric and gastroesophageal cancer; ETX2514, a novel ß-lactamase inhibitor that is in Phase II cUTI trial for the treatment of acinetobacter baumannii; and ZL-2301, which is in Phase III clinical trial to treat HCC. The company's drug candidates also comprise ZL-3101, a novel steroid-sparing topical product that is in Phase II clinical trial for the treatment of eczema and psoriasis; and ZL-2302 to treat non-small cell lung cancer. The company, through its subsidiary, Zai Lab (Shanghai) Co. Ltd., has a collaboration agreement with the NovoCure Limited to perform clinical studies, sell, and import tumor treating field products in the field of oncology. Zai Lab Limited was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.
Industry: Biopharmaceuticals

4560 Jinke Road
Bldg. 1, 4/F
SHANGHAI
SHANGHAI 201210
CN

People also watch

Gold

2,397.43 Price
+0.010% 1D Chg, %
Long position overnight fee -0.0196%
Short position overnight fee 0.0114%
Overnight fee time 21:00 (UTC)
Spread 0.30

US100

19,736.40 Price
-0.290% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 1.8

XRP/USD

0.60 Price
-3.000% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

66,655.00 Price
-2.230% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading